|
The BIO stock that I am heavily invested in, and following will most likely be the production facility to get it to market first. IBIO stock has risen from 2.20 a share on last Monday to $6.89 a share currently. They use a plant base in their fastpharming, and are capable of multi-millions of doses. Their stock rocketed to $55 a share during the 2009 swine flu, and to $32 a share during it's relapse in 2014.
|